Innospec Inc. $IOSP Shares Bought by Vanguard Group Inc.

Vanguard Group Inc. raised its holdings in Innospec Inc. (NASDAQ:IOSP) by 0.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,210,768 shares of the specialty chemicals company’s stock after purchasing an additional 30,031 shares during the period. Vanguard Group Inc. owned about 12.78% of Innospec worth $304,220,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Principal Financial Group Inc. raised its position in shares of Innospec by 2.4% in the 1st quarter. Principal Financial Group Inc. now owns 132,493 shares of the specialty chemicals company’s stock valued at $12,554,000 after purchasing an additional 3,045 shares in the last quarter. Rhumbline Advisers raised its position in shares of Innospec by 9.3% in the 1st quarter. Rhumbline Advisers now owns 77,760 shares of the specialty chemicals company’s stock valued at $7,368,000 after purchasing an additional 6,602 shares in the last quarter. Envestnet Asset Management Inc. raised its position in shares of Innospec by 14.9% in the 4th quarter. Envestnet Asset Management Inc. now owns 27,554 shares of the specialty chemicals company’s stock valued at $3,033,000 after purchasing an additional 3,578 shares in the last quarter. Wells Fargo & Company MN raised its position in shares of Innospec by 7.1% in the 4th quarter. Wells Fargo & Company MN now owns 55,702 shares of the specialty chemicals company’s stock valued at $6,131,000 after purchasing an additional 3,696 shares in the last quarter. Finally, Deutsche Bank AG raised its position in shares of Innospec by 60.5% during the 4th quarter. Deutsche Bank AG now owns 21,983 shares of the specialty chemicals company’s stock valued at $2,419,000 after acquiring an additional 8,286 shares in the last quarter. 96.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on IOSP shares. Wall Street Zen lowered Innospec from a “buy” rating to a “hold” rating in a research report on Tuesday, May 6th. Seaport Res Ptn raised Innospec from a “hold” rating to a “strong-buy” rating in a research report on Monday, April 21st.

Innospec Trading Down 0.6%

IOSP stock opened at $82.94 on Monday. The firm has a market cap of $2.06 billion, a P/E ratio of 106.33 and a beta of 1.07. Innospec Inc. has a 12-month low of $74.10 and a 12-month high of $128.35. The stock’s 50 day simple moving average is $84.36 and its 200 day simple moving average is $91.25.

Innospec (NASDAQ:IOSP) last posted its quarterly earnings results on Tuesday, August 5th. The specialty chemicals company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.09. The business had revenue of $439.70 million for the quarter, compared to analyst estimates of $440.70 million. Innospec had a return on equity of 10.89% and a net margin of 1.08%. The business’s revenue was up 1.1% compared to the same quarter last year. During the same period in the prior year, the company posted $1.39 EPS. On average, research analysts forecast that Innospec Inc. will post 6.18 EPS for the current fiscal year.

Innospec Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.